US Patent Issued to Medicinal Bioconvergence Research Center on Dec. 6 for "Method for controlling cancer metastasis or cancer cell migration by modulating the cellular level of lysyl tRNA synthetase" (South Korean Inventors)

Press/Media: Press / Media

Period2016 Dec 7

Media coverage

1

Media coverage

  • TitleUS Patent Issued to Medicinal Bioconvergence Research Center on Dec. 6 for "Method for controlling cancer metastasis or cancer cell migration by modulating the cellular level of lysyl tRNA synthetase" (South Korean Inventors)
    Media name/outletUS Fed News
    Country/TerritoryUnited States
    Date16/12/7
    PersonsSunghoon Kim